Skip to main content

Table 3 Immunohistochemistry results

From: Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification

  CK14 CK5/6 GATA3 FOXA1
< 1% 60 (60.0%) 24 (24.0%) 8 (8.0%) 15 (15.0%)
1~10% 12 (12.0%) 35 (35.0%) 11 (11.0%) 15 (15.0%)
11~25% 15 (15.0%) 16 (16.0%) 14 (14.0%) 20 (20.0%)
> 25% 13 (13.0%) 25 (25.0%) 67 (67.0%) 50 (50.0%)